DSIJ Mindshare

Sun Pharma launched Drizalma Sprinkle for treatment of various disorders

DSIJ Intelligence 0 2683 Article rating: 5.0

A subsidiary of Sun Pharma launched Drizalma Sprinkle in the United States. It is the first and only USFDA approved sprinkle formulation of Drizalma Sprinkle which is delayed-release duloxetine capsules used in treatment of patients suffering from neuro-psychiatric and/or pain disorder accompanied with difficulty swallowing.

ARSS Infra at upper circuit on 2 order wins in Odisha

Apurva Joshi 0 1471 Article rating: 3.0

ARSS Infrastructure Projects Limited has won an order of Rs. 50,46,70,085 for "Construction of Roadbed, Minor Bridges, Service Buildings including Amenities, Passenger Amenities at Stations and related works along with General Electrical Works in connection with 3rd line between Rayagada (KM: 343.90) to Jimidipeta (KM: 356.518) on Waltair Division of East Coast Railway in Odisha State.

RSS
First62616262626362646266626862696270Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR